Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for CGEM

Stock NameCullinan Oncology LLC
TickerCGEM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025
(RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc
Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.
American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) CGEM holdings

DateNumber of CGEM Shares HeldBase Market Value of CGEM SharesLocal Market Value of CGEM SharesChange in CGEM Shares HeldChange in CGEM Base ValueCurrent Price per CGEM Share HeldPrevious Price per CGEM Share Held
2025-11-11 (Tuesday)39,299USD 306,532CGEM holding increased by 14147USD 306,5320USD 14,147 USD 7.79999 USD 7.44001
2025-11-10 (Monday)39,299CGEM holding increased by 102USD 292,385CGEM holding increased by 10559USD 292,385102USD 10,559 USD 7.44001 USD 7.18999
2025-11-07 (Friday)39,197USD 281,826CGEM holding decreased by -6272USD 281,8260USD -6,272 USD 7.18999 USD 7.35
2025-11-06 (Thursday)39,197CGEM holding increased by 102USD 288,098CGEM holding increased by 2314USD 288,098102USD 2,314 USD 7.35 USD 7.30999
2025-11-05 (Wednesday)39,095USD 285,784CGEM holding decreased by -3519USD 285,7840USD -3,519 USD 7.30999 USD 7.4
2025-11-04 (Tuesday)39,095CGEM holding increased by 103USD 289,303CGEM holding decreased by -15225USD 289,303103USD -15,225 USD 7.4 USD 7.81001
2025-11-03 (Monday)38,992USD 304,528CGEM holding decreased by -33143USD 304,5280USD -33,143 USD 7.81001 USD 8.66001
2025-10-31 (Friday)38,992USD 337,671CGEM holding increased by 42891USD 337,6710USD 42,891 USD 8.66001 USD 7.56001
2025-10-30 (Thursday)38,992CGEM holding increased by 515USD 294,780CGEM holding decreased by -1108USD 294,780515USD -1,108 USD 7.56001 USD 7.69
2025-10-29 (Wednesday)38,477CGEM holding increased by 206USD 295,888CGEM holding decreased by -29033USD 295,888206USD -29,033 USD 7.69 USD 8.49001
2025-10-28 (Tuesday)38,271USD 324,921CGEM holding increased by 16457USD 324,9210USD 16,457 USD 8.49001 USD 8.05999
2025-10-27 (Monday)38,271USD 308,464CGEM holding increased by 11481USD 308,4640USD 11,481 USD 8.05999 USD 7.76
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00BYXG2H39

Show aggregate share trades of CGEM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1028.0007.380 7.442USD 759 9.27
2025-11-06BUY1027.8207.060 7.136USD 728 9.29
2025-11-04BUY1037.8007.360 7.404USD 763 9.31
2025-10-30BUY5158.0907.550 7.604USD 3,916 9.33
2025-10-29BUY2067.6908.570 8.482USD 1,747 9.34
2025-10-22SELL-4088.1208.650 8.597USD -3,508 9.38 Profit of 318 on sale
2025-10-20BUY2048.5608.580 8.578USD 1,750 9.38
2025-10-17BUY5097.8558.660 8.579USD 4,367 9.39
2025-10-15BUY8088.6308.650 8.648USD 6,988 9.40
2025-10-03BUY7285.9006.020 6.008USD 4,374 9.43
2025-10-02BUY1045.7506.050 6.020USD 626 9.45
2025-09-30BUY2085.9306.055 6.042USD 1,257 9.49
2025-09-26BUY2085.9606.100 6.086USD 1,266 9.53
2025-09-25BUY2085.9906.100 6.089USD 1,267 9.55
2025-09-18BUY1056.3406.400 6.394USD 671 9.59
2025-09-17BUY3155.9306.410 6.362USD 2,004 9.61
2025-08-20SELL-4087.4707.626 7.610USD -3,105 9.67 Profit of 838 on sale
2025-07-30BUY4048.1608.590 8.547USD 3,453 9.74
2025-07-17SELL-2047.7707.960 7.941USD -1,620 9.84 Profit of 388 on sale
2025-07-11SELL-8247.7007.830 7.817USD -6,441 9.90 Profit of 1,717 on sale
2025-07-07BUY3067.4207.770 7.735USD 2,367 9.97
2025-07-02BUY5,6657.7608.050 8.021USD 45,439 10.00
2025-06-11BUY2068.9809.250 9.223USD 1,900 10.09
2025-06-10BUY2069.0309.160 9.147USD 1,884 10.10
2025-06-04SELL-1039.0709.360 9.331USD -961 10.13 Profit of 83 on sale
2025-04-23BUY1038.3808.790 8.749USD 901 10.79
2025-04-10SELL-8167.5807.610 7.607USD -6,207 11.08 Profit of 2,836 on sale
2025-04-08SELL-1027.3207.830 7.779USD -793 11.16 Profit of 345 on sale
2025-04-07SELL-1027.2507.390 7.376USD -752 11.21 Profit of 391 on sale
2025-04-04SELL-5157.4107.615 7.594USD -3,911 11.25 Profit of 1,885 on sale
2025-04-01BUY4207.5007.550 7.545USD 3,169 11.34
2025-03-31SELL-3127.5707.900 7.867USD -2,455 11.39 Profit of 1,098 on sale
2025-03-21BUY2,7458.5208.760 8.736USD 23,980 11.63
2025-03-14SELL-1,5208.7909.010 8.988USD -13,662 11.83 Profit of 4,317 on sale
2025-03-07SELL-1908.7109.090 9.052USD -1,720 12.07 Profit of 572 on sale
2025-03-04SELL-958.1308.315 8.296USD -788 12.24 Profit of 375 on sale
2025-02-25BUY1908.5608.830 8.803USD 1,673 12.57
2025-02-19SELL-949.4309.470 9.466USD -890 12.83 Profit of 316 on sale
2025-02-13BUY2829.5909.960 9.923USD 2,798 13.10
2025-02-12BUY949.8909.950 9.944USD 935 13.16
2025-02-11BUY3769.81010.270 10.224USD 3,844 13.23
2024-12-30SELL-2,88512.20012.280 12.272USD -35,405 14.39 Profit of 6,096 on sale
2024-11-18SELL-1,50013.45014.145 14.076USD -21,113 16.01 Profit of 2,905 on sale
2024-11-08SELL-10016.02016.450 16.407USD -1,641 16.01 Loss of -40 on sale
2024-10-21SELL-10016.20016.790 16.731USD -1,673 0.00 Loss of -1,673 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1991,7130453,13720.2%
2025-09-1829,90964374,3228.0%
2025-09-1729,113561152,08119.1%
2025-09-1641,7652156,36626.7%
2025-09-1569,037556213,45032.3%
2025-09-1276,0840383,50219.8%
2025-09-1166,615867581,52011.5%
2025-09-1055,0970308,72517.8%
2025-09-09106,4910278,73338.2%
2025-09-0844,9790172,18226.1%
2025-09-0592,5842,960314,97529.4%
2025-09-04218,97713,252745,97129.4%
2025-09-0359,5350162,54436.6%
2025-09-0230,2150107,25628.2%
2025-08-2928,9550102,69028.2%
2025-08-2839,008089,89543.4%
2025-08-2750,5440153,48132.9%
2025-08-2638,6843378,65710.2%
2025-08-2517,620058,53130.1%
2025-08-2273,1000173,43542.1%
2025-08-2127,559085,31232.3%
2025-08-2037,739091,41841.3%
2025-08-1937,960083,52645.4%
2025-08-1877,2120180,13542.9%
2025-08-1537,9960114,06733.3%
2025-08-1415,1790186,7068.1%
2025-08-1325,9030130,51119.8%
2025-08-1244,9730119,05337.8%
2025-08-1141,962128103,18340.7%
2025-08-0867,3042,573153,71443.8%
2025-08-0780,102176173,93646.1%
2025-08-0621,373051,51641.5%
2025-08-0522,741058,65038.8%
2025-08-0426,114093,27628.0%
2025-08-0138,24057976,87449.7%
2025-07-3135,0275868,86450.9%
2025-07-3080,5000739,89910.9%
2025-07-2958,3939130,45944.8%
2025-07-2827,557046,54859.2%
2025-07-2521,73617636,20960.0%
2025-07-2454,73018130,09542.1%
2025-07-2377,9670133,95558.2%
2025-07-2249,802089,67155.5%
2025-07-2127,480040,11268.5%
2025-07-1829,606050,25158.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.